Oct 24, 2022 (Osaka, Japan) - Linical Co., Ltd. is pleased to announce that it has established a subsidiary in Italy aiming for expanding its business in Europe.
Linical is a Global CRO (Contract Research Organization) headquartered in Japan, with offices in multiple locations across Europe, North America and Asia, and continues to expand its business worldwide. The newly established Linical Italy SRL as our 10th country base in Europe, following Germany, Spain, France, and the UK offers clinical trials services to the pharmaceutical and biotech industries in Italy. Italy is home to many traditional pharmaceutical companies and is an important pharmaceutical market with prospects for continued growth.
As drug development is becoming more international and large-scale, the importance of a global CRO who can provide high-quality services in any region is increasing. Linical strives to become a true clinical development partner trusted by our pharmaceutical customers and contribute to bringing new drugs to patients who need them.
■About Linical Italy
|
Company Name |
Linical Italy SRL |
|
Address |
Via Uberto Visconti di Modrone 2, Milano, Italy |
|
Representative Directors |
Keigo Tsujimoto, Isao Sakamoto and Rafael Romero Jimenez |
|
Establishment date |
Oct 7, 2022 |
|
Capital amount |
10,000 EUR (wholly owned by Linical Europe Holding GmbH) |
|
Number of employees |
5 |
|
Business |
CRO business (clinical trial services) |